Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Public ClinicalTrials.gov record NCT02858726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Study identification
- NCT ID
- NCT02858726
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Cara Therapeutics, Inc.
- Industry
- Enrollment
- 226 participants
Conditions and interventions
Conditions
Interventions
- CR845 0.5 mcg/kg Drug
- CR845 1 mcg/kg Drug
- CR845 1.5mcg/kg Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2016
- Primary completion
- Mar 13, 2017
- Completion
- Mar 13, 2017
- Last update posted
- Jul 28, 2020
2016 – 2017
United States locations
- U.S. sites
- 29
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cara Therapeutics Investigator Site | Phoenix | Arizona | 85035 | — |
| Cara Therapeutics Study Site | Pine Bluff | Arkansas | 71603 | — |
| Cara Therapeutics Investigator Site | Long Beach | California | 90806 | — |
| Cara Therapeutics Study Site | Northridge | California | 91324 | — |
| Cara Therapeutics Study Site | Whittier | California | 90603 | — |
| Cara Therapeutics Study Site | Denver | Colorado | 80218 | — |
| Cara Therapeutics Study Site | Hollywood | Florida | 33024 | — |
| Cara Therapeutics Study Site | Tampa | Florida | 33614 | — |
| Cara Therapeutics Study Site | Winter Park | Florida | 32789 | — |
| Cara Therapeutics Study Site | Augusta | Georgia | 30909 | — |
| Cara Therapeutics Study Site | Meridian | Idaho | 83642 | — |
| Cara Therapetics Study Site | Creve Coeur | Missouri | 63141 | — |
| Cara Therapeutics Study Site | Kansas City | Missouri | 64111 | — |
| Cara Therapeutics Study Site | Kansas City | Missouri | 64131 | — |
| Cara Therapeutics Study Site | Omaha | Nebraska | 68124 | — |
| Cara Therapetics Investigator Site | Albuquerque | New Mexico | 87109 | — |
| Cara Therapeutics Study Site | Gallup | New Mexico | 87301 | — |
| Cara Therapeutics Study Site | College Point | New York | 11385 | — |
| Cara Therapeutics Investigator Site | Mineola | New York | 11501 | — |
| Cara Therapeutics Investigator Site | Wilmington | North Carolina | 28401 | — |
| Cara Therapeutics Study Site | Winston-Salem | North Carolina | 27103 | — |
| Cara Therapeutics Study Site | Bethlehem | Pennsylvania | 18017 | — |
| Cara Therapeutics Investigator Site | Philadelphia | Pennsylvania | 19140 | — |
| Cara Therapeutics Study Site | Chattanooga | Tennessee | 37408 | — |
| Cara Therapetics Study Site | Knoxville | Tennessee | 37920 | — |
| Cara Therapeutics Study Site | San Antonio | Texas | 78221 | — |
| Cara Therapeutics Study Site | San Antonio | Texas | 78229 | — |
| Cara Therapeutics Study Site | San Antonio | Texas | 78251 | — |
| Cara Therapeutics Study Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02858726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 28, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02858726 live on ClinicalTrials.gov.